Product Information
CLINDAMYCIN PHOSPHATE 1% FOAM is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $2.2096 per GM under NDC 51672419403. Its NADAC has been published 154 times since Nov 23, 2022.
FDA first approved this application on Mar 11, 2020. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672419403
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA210004FDA Approved
3/11/2020
TE Code
AT
On Market Since
10/1/2022
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has been published 154 times since Nov 23, 2022, and over the history we have for it it has declined 51.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2096 per GM |
|---|---|
| All-time high | $4.5077 (May 10, 2023) |
| All-time low | $2.2096 (Sep 23, 2026) |
| 52-week high | $3.2835 |
| 52-week low | $2.2096 |
| Median price | $3.3225 |
| Average price | $3.2520 |
| Largest weekly change | -26.0% (May 22, 2024) |
| Weeks tracked | 154 |
| Tracking since | Nov 23, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PHOSPHATE 1% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOSPHATE 1% FOAM, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $2.2096 per GM (NDC 51672419403), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PHOSPHATE 1% FOAM changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has declined 51.0%. It has been tracked across 154 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOSPHATE 1% FOAM?
Since Nov 23, 2022, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has ranged from a low of $2.2096 (Sep 23, 2026) to a high of $4.5077 (May 10, 2023), with a median of $3.3225 per GM.
Are there cheaper alternatives to CLINDAMYCIN PHOSPHATE 1% FOAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN PHOSPHATE 1% FOAM, is $1.8305 per GM — about 17% below CLINDAMYCIN PHOSPHATE 1% FOAM.
Who manufactures CLINDAMYCIN PHOSPHATE 1% FOAM?
CLINDAMYCIN PHOSPHATE 1% FOAM (NDC 51672419403) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.